Emergent BioSolutions CEO: ‘Confrontational’ coverage of vaccine maker puts a target on ‘people doing good’

As the CEO of a 2,000-plus person Maryland-based company involved in the COVID-19 response, I have a high tolerance for the obligations that come with it — like spending endless hours trying to explain complicated manufacturing processes to reporters who just learned we existed. Or battling back the misinformation that is used to find fault with the people who are the spine of our nation’s world-leading response to this pandemic. But it pains me to watch how this negative attention affects our workforce. We talk about front line health care workers a lot, as we should. They are extraordinary, and we could not have done this without them this past year.